English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 242 Help

Selected(0)Clear Items/Page:    Sort:
Supramolecular prodrug vesicles for selective antimicrobial therapy employing a chemo-photodynamic strategy Journal article
Sun, Hao, Li, Shengke, Liu, Qian, Zuo, Minzan, Tian, Xueqi, Wang, Kaiya, Hu, Xiao Yu. Supramolecular prodrug vesicles for selective antimicrobial therapy employing a chemo-photodynamic strategy[J]. Chinese Chemical Letters, 2025, 36(3), 109999.
Authors:  Sun, Hao;  Li, Shengke;  Liu, Qian;  Zuo, Minzan;  Tian, Xueqi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:9.4/7.3 | Submit date：2025/01/22
Supramolecular Prodrug  Selective Antibacterial Activity  Host-guest Complex  Cavitand  Combination Therapy  
The role of hospital pharmacists in supporting the appropriate and safe use of CGT/ATMPs: a scoping review of current insights Review article
2025
Authors:  Shi, Junnan;  Chen, Xianwen;  Hu, Hao;  Ung, Carolina Oi Lam
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.7/3.1 | Submit date：2025/01/22
Advanced Therapy Medicinal Products  Cell And Gene Therapy  Hospital Pharmacy  Pharmaceutical Care  Pharmacy Practice  Regeneration Medicine  
Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma Journal article
Zou, Huimin, Lai, Yunfeng, Chen, Xianwen, Ung, Carolina Oi Lam, Hu, Hao. Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma[J]. Therapeutic Advances in Gastroenterology, 2025, 18, 1-13.
Authors:  Zou, Huimin;  Lai, Yunfeng;  Chen, Xianwen;  Ung, Carolina Oi Lam;  Hu, Hao
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.9/4.0 | Submit date：2025/01/22
Camrelizumab  Cost-effectiveness Analysis  Hepatocellular Carcinoma  Partitioned Survival Model  Rivoceranib  
Using system dynamics modeling approach to strengthen health systems to combat cancer: a systematic literature review Review article
2025
Authors:  Chen, Xianwen;  Cai, Kuangyuan;  Xue, Yan;  Ung, Carolina Oi Lam;  Hu, Hao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.9/2.9 | Submit date：2025/01/22
Cancer Control  Cancer Diagnosis  Cancer Screening  Cancer Treatment  System Dynamics Modeling  
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study Journal article
Hu, Ying, Chen, Xianwen, Zou, Huimin, Zhang, Hao, Ni, Qi, Li, Yijun, Ung, Carolina Oi Lam, Hu, Hao, Mu, Yiming. Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study[J]. Advances in Therapy, 2024.
Authors:  Hu, Ying;  Chen, Xianwen;  Zou, Huimin;  Zhang, Hao;  Ni, Qi; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.4/4.0 | Submit date：2024/12/26
China  Modeling  Semaglutide  Type 2 Diabetes Mellitus  
Polyclonal-to-monoclonal transition in colorectal precancerous evolution Journal article
Lu, Zhaolian, Mo, Shanlan, Xie, Duo, Zhai, Xiangwei, Deng, Shanjun, Zhou, Kantian, Wang, Kun, Kang, Xueling, Zhang, Hao, Tong, Juanzhen, Hou, Liangzhen, Hu, Huijuan, Li, Xuefei, Zhou, Da, Lee, Leo Tsz On, Liu, Li, Zhu, Yaxi, Yu, Jing, Lan, Ping, Wang, Jiguang, He, Zhen, He, Xionglei, Hu, Zheng. Polyclonal-to-monoclonal transition in colorectal precancerous evolution[J]. Nature, 2024, 636(8041), 233–240.
Authors:  Lu, Zhaolian;  Mo, Shanlan;  Xie, Duo;  Zhai, Xiangwei;  Deng, Shanjun; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:50.5/54.4 | Submit date：2024/12/05
Utilization of Immune Checkpoint Inhibitors in Human Epidermal Growth Factor Receptor 2–Negative, Advanced Metastatic, or Unresectable Gastric Cancer Under All Combined Positive Score Grading: Evaluation of Efficacy Based on Individual Patient Data Reconstruction and Secondary Analyses Review article
2024
Authors:  Deng, Ning;  Yan, Zhijing;  Wang, Shengpeng;  Song, Menghuan;  Hu, Hao
Favorite | TC[Scopus]:0  IF:3.2/3.0 | Submit date：2024/12/26
Gastric Cancer  Immune Checkpoint Inhibitor  Individual Patient Data  Pd-1  Pd-l1  
Cyclododecane-based high-intactness and clean transfer method for fabricating suspended two-dimensional materials Journal article
Wang, Zhao, Liu, Wenlin, Shao, Jiaxin, Hao, He, Wang, Guorui, Zhao, Yixuan, Zhu, Yeshu, Jia, Kaicheng, Lu, Qi, Yang, Jiawei, Zhang, Yanfeng, Tong, Lianming, Song, Yuqing, Sun, Pengzhan, Mao, Boyang, Hu, Chenguo, Liu, Zhongfan, Lin, Li, Peng, Hailin. Cyclododecane-based high-intactness and clean transfer method for fabricating suspended two-dimensional materials[J]. Nature Communications, 2024, 15(1), 6957.
Authors:  Wang, Zhao;  Liu, Wenlin;  Shao, Jiaxin;  Hao, He;  Wang, Guorui; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:14.7/16.1 | Submit date：2024/09/03
A New Generation of Multimilliwatt-Class Colloidal Quantum-Dot Lasers at Full Colors Journal article
Zhang, Hao, Jiao, Kerong, Hu, Yongsheng, Huang, Zhigao, Wu, Yuting, Song, Qingxiu, Ta, Van Duong, Sun, Handong, Shen, Hua, Wang, Yue, Zhang, Hao, Jiao, Kerong, Hu, Yongsheng, Huang, Zhigao, Wu, Yuting, Song, Qingxiu, Ta, Van Duong, Sun, Handong, Shen, Hua, Wang, Yue. A New Generation of Multimilliwatt-Class Colloidal Quantum-Dot Lasers at Full Colors[J]. Advanced Materials, 2024, 2413828.
Authors:  Zhang, Hao;  Jiao, Kerong;  Hu, Yongsheng;  Huang, Zhigao;  Wu, Yuting; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:27.4/30.2 | Submit date：2024/12/26
Colloidal Quantum Dots  Double-clad Fiber  Full-color Laser  Optical Gain  Quasi-steady-state Pumping  
Challenges and strategies of developing internet hospital: Combining qualitative interview and documentary research Journal article
Lai, Yunfeng, Ho, Qiong, Wang, Yao, Liang, Xiaonan, Xue, Yan, Ung, Carolina Oi Lam, Li, Meng, Yao, Dongning, Liu, Buping, Bian, Ying, Xie, Zhirong, Hu, Hao. Challenges and strategies of developing internet hospital: Combining qualitative interview and documentary research[J]. Digital Health, 2024, 10, 20552076241310075.
Authors:  Lai, Yunfeng;  Ho, Qiong;  Wang, Yao;  Liang, Xiaonan;  Xue, Yan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.9/3.7 | Submit date：2025/01/13
Internet Hospital  Development Challenge  Development Strategy  Service Model  China